These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 28609608)

  • 1. Voriconazole Concentrations in Plasma and Epithelial Lining Fluid after Inhalation and Oral Treatment.
    Andersen CU; Sønderskov LD; Bendstrup E; Voldby N; Cass L; Ayrton J; Hilberg O
    Basic Clin Pharmacol Toxicol; 2017 Nov; 121(5):430-434. PubMed ID: 28609608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Penetration of anti-infective agents into pulmonary epithelial lining fluid: focus on antifungal, antitubercular and miscellaneous anti-infective agents.
    Rodvold KA; Yoo L; George JM
    Clin Pharmacokinet; 2011 Nov; 50(11):689-704. PubMed ID: 21973267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrapulmonary penetration of voriconazole in patients receiving an oral prophylactic regimen.
    Capitano B; Potoski BA; Husain S; Zhang S; Paterson DL; Studer SM; McCurry KR; Venkataramanan R
    Antimicrob Agents Chemother; 2006 May; 50(5):1878-80. PubMed ID: 16641467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between trough plasma and epithelial lining fluid concentrations of voriconazole in lung transplant recipients.
    Heng SC; Snell GI; Levvey B; Keating D; Westall GP; Williams TJ; Whitford H; Nation RL; Slavin MA; Morrissey O; Kong DC
    Antimicrob Agents Chemother; 2013 Sep; 57(9):4581-3. PubMed ID: 23817382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose tolerability of chronically inhaled voriconazole solution in rodents.
    Tolman JA; Nelson NA; Bosselmann S; Peters JI; Coalson JJ; Wiederhold NP; Williams RO
    Int J Pharm; 2009 Sep; 379(1):25-31. PubMed ID: 19524030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of voriconazole in seven body fluids of adult horses after repeated oral dosing.
    Passler NH; Chan HM; Stewart AJ; Duran SH; Welles EG; Lin HC; Ravis WR
    J Vet Pharmacol Ther; 2010 Feb; 33(1):35-41. PubMed ID: 20444023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of sex and AIDS status on the plasma and intrapulmonary pharmacokinetics of rifampicin.
    Conte JE; Golden JA; Kipps JE; Lin ET; Zurlinden E
    Clin Pharmacokinet; 2004; 43(6):395-404. PubMed ID: 15086276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PHARMACOKINETICS OF ORALLY ADMINISTERED VORICONAZOLE IN AFRICAN PENGUINS (SPHENISCUS DEMERSUS) AFTER SINGLE AND MULTIPLE DOSES.
    Hyatt MW; Wiederhold NP; Hope WW; Stott KE
    J Zoo Wildl Med; 2017 Jun; 48(2):352-362. PubMed ID: 28749255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of voriconazole after intravenous and oral administration to healthy cats.
    Vishkautsan P; Papich MG; Thompson GR; Sykes JE
    Am J Vet Res; 2016 Sep; 77(9):931-9. PubMed ID: 27580104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of different pharmacokinetic models to describe and predict pharmacokinetics of voriconazole in magellanic penguins following oral administration.
    Parsley RA; Mutlow AG; Hansted J; Taverne FJ; Tell LA; Gehring R
    J Vet Pharmacol Ther; 2019 Jan; 42(1):74-84. PubMed ID: 30175535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zanamivir pharmacokinetics and pulmonary penetration into epithelial lining fluid following intravenous or oral inhaled administration to healthy adult subjects.
    Shelton MJ; Lovern M; Ng-Cashin J; Jones L; Gould E; Gauvin J; Rodvold KA
    Antimicrob Agents Chemother; 2011 Nov; 55(11):5178-84. PubMed ID: 21896909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic and Pharmacodynamic Properties of Oral Voriconazole in Patients with Invasive Fungal Infections.
    Wang T; Xie J; Wang Y; Zheng X; Lei J; Wang X; Dong H; Yang Q; Chen L; Xing J; Dong Y
    Pharmacotherapy; 2015 Sep; 35(9):797-804. PubMed ID: 26406771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and distribution of voriconazole in body fluids of dogs after repeated oral dosing.
    Lemetayer JD; Dowling PM; Taylor SM; Papich MG
    J Vet Pharmacol Ther; 2015 Oct; 38(5):451-6. PubMed ID: 25691353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aerosol-based efficient delivery of clarithromycin, a macrolide antimicrobial agent, to lung epithelial lining fluid and alveolar macrophages for treatment of respiratory infections.
    Togami K; Chono S; Morimoto K
    J Aerosol Med Pulm Drug Deliv; 2012 Apr; 25(2):110-5. PubMed ID: 22360316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of proton pump inhibitor on plasma voriconazole concentration in Thai patients.
    Chayakulkeeree M; Poovipirom N; Siengwattana P; Maneerattanaporn M
    J Med Assoc Thai; 2015 Mar; 98(3):232-7. PubMed ID: 25920292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioavailability of voriconazole in hospitalised patients.
    Veringa A; Geling S; Span LF; Vermeulen KM; Zijlstra JG; van der Werf TS; Kosterink JG; Alffenaar JC
    Int J Antimicrob Agents; 2017 Feb; 49(2):243-246. PubMed ID: 28012684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of systemic voriconazole in equine keratomycosis based on pharmacokinetic-pharmacodynamic analysis of tear fluid following oral administration.
    Tamura N; Okano A; Kuroda T; Niwa H; Kusano K; Matsuda Y; Fukuda K; Mita H; Nagata S
    Vet Ophthalmol; 2020 Jul; 23(4):640-647. PubMed ID: 32383526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A retrospective, multicenter study of voriconazole trough concentrations and safety in patients with Child-Pugh class C cirrhosis.
    Wang T; Yan M; Tang D; Xue L; Zhang T; Dong Y; Zhu L; Wang X; Dong Y
    J Clin Pharm Ther; 2018 Dec; 43(6):849-854. PubMed ID: 29893015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serial pentamidine levels in bronchial epithelial lining fluid after aerosol administration.
    Yamamoto H; Koizumi T; Miyahara T; Kaneki T; Kubo K
    Respiration; 2001; 68(5):506-8. PubMed ID: 11694814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrapulmonary pharmacokinetics and pharmacodynamics of itraconazole and 14-hydroxyitraconazole at steady state.
    Conte JE; Golden JA; Kipps J; McIver M; Zurlinden E
    Antimicrob Agents Chemother; 2004 Oct; 48(10):3823-7. PubMed ID: 15388441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.